AKT2 and lung carcinoma: We report that Akt1 ablation inhibits the incidence and development of lung tumors, Akt2 deficiency markedly accelerates lung tumor initiation and Akt3 ablation slightly enhances tumor progression in this mouse model of lung cancer.